Cassian Yee

Cassian Yee, M.D., is a Professor in the Department of Melanoma Medical Oncology and the Department of Immunology at The University of Texas MD Anderson Cancer Center, Houston, TX. He serves as Director of the Program for T Cell-Based Therapies (ProTCT) and the Solid Tumor Cell Therapy Program within the Division of Cancer Medicine, reflecting his leadership in advancing innovative immunotherapies for cancer.

His research interests focus on melanoma, cancer immunology, and T cell-based therapies, particularly in developing and refining cellular immunotherapies for solid tumors. His dual appointments underscore a multidisciplinary approach integrating clinical oncology with fundamental immunological research.

Dr. Yee's work is central to translational and clinical research in oncology, aiming to bridge laboratory discoveries with therapeutic applications for patients. Though specific publications and trends are not listed in the provided text, his leadership in cell therapy programs indicates a strong focus on adoptive T cell transfer, tumor antigen targeting, and immune modulation in cancer treatment.

Honors and Awards

Advising and Grants: While no specific students or grants are listed, Dr. Yee likely mentors trainees and leads funded research programs given his directorial and professorial roles in major research initiatives. His position suggests involvement in significant federal or institutional grants related to cancer immunotherapy and cell therapy development.

Labs and Teams: Dr. Yee leads the Program for T Cell-Based Therapies (ProTCT) and the Solid Tumor Cell Therapy Program, which are likely interdisciplinary teams involving clinicians, immunologists, and translational scientists focused on developing next-generation cellular treatments for solid cancers.